Argenta expands collaboration with Genentech to include BioFocus

Argenta, a service division of Galapagos NV, announced today it has signed a contract extension with Galapagos NV, a member of the Roche Group. The extended agreement expands the portfolio of projects which are in collaboration with Genentech and allows Genentech to place projects directly into Galapagos’ other service division, BioFocus.

Study supports screening in men at higher genetic risk of prostate cancer

Men at higher risk of prostate cancer due to genetic changes may benefit from regular screening, according to preliminary results from the first multinational study of patients with known prostate cancer predisposition genes.

Scientists have already found a number of genetic factors that increase prostate cancer risk, including heritable mutations in the genes BRCA1 and BRCA2. These mutations are not common but can have major impact, as a BRCA2 mutation increases risk by up to seven-fold while a BRCA1 mutation is thought to double risk in men under 65.

New 1-to-4 Reagent MultiFlo Microplate Dispenser smplifies dispensing processes

BioTek’s new MultiFlo Microplate Dispenser uses multiple technologies to dispense multiple reagents into multiple microplate types. This all-in-one dispenser saves bench space and transfer time, and also eliminates plate setup steps, thus simplifying the dispensing process.

The MultiFlo dispenses up to four independent, parallel reagents in volumes from 1µL to 3mL, and microplates from 6- to 1536-well, including low-profile, standard height, deep well and even microtubes.

Nexxis iLAB 5.02: instrument integration into a single package

Labtronics Inc has released Nexxis iLAB 5.02, a total lab automation system.  It is the first product of its kind that integrates ELN, SDMS and instrument integration into a single package that is ready to go, out of the box. It enhances the value of any existing LIMS by providing missing functionality not found in the LIMS.

Specialist business unit of university spins-out to form R&D oncology company

Preclinical Oncology Services Limited (PRECOS), a pre-clinical research and development service with a specific focus on oncology, announces its official launch following its spin-out from the University of Nottingham.

The newly formed company combines the innovation of one of the UK's leading universities with the scientific background and expertise of multi-disciplinary scientists.